Polyamine Involvement in the Growth of Hormone-responsive and -resistant Human Breast Cancer Cells in Culture

Patricia Glikman, Andrea Manni, Laurence Demers, Mary Bartholomew

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Recent evidence indicates that hormone-responsive but not -resistant human breast cancer cells in culture are sensitive to the antiproliferative effect of the polyamine (PA) biosynthetic inhibitor a-difluoromethylor-nithine (DFMO). The present experiments were designed to investigate the potential differential involvement of the PA pathway in the growth of these different biological subtypes of human breast cancer. Thus, we evaluated the effect of DFMO on proliferation, ornithine decarboxylase (ODC) activity, and PA levels of the hormone-dependent MCF-7 and -independent MDA-MB-231 breast cancer cell lines. When tested at comparable cell density, the two cell lines had similar levels of ODC activity and PA. Administration of DFMO (0.01, 0.1, 1, 4 mm) for 6 days caused a similar dose-dependent inhibition of proliferation (up to approximately 15% of control) associated with suppression of ODC activity to undetectable levels at the highest dose. In both cell lines, putrescine and spermidine levels were maximally suppressed by doses of DFMO > 0.1 mM. Higher doses of DFMO (1 and 4 mM) also suppressed spermine levels to approximately 60% of control. In detailed time-course studies, DFMO administration (0.1 mM) similarly suppressed by 80% the rise in ODC observed in both cell lines following a medium change. At all time points, putrescine and spermidine levels were likewise suppressed to a similar extent. Addition of putrescine (0.1-2.5 mM) to DFMO-treated cells repleted cellular PA levels and restored growth to approximately 80% of control in both cell lines. We conclude that, under these experimental conditions, PA are similarly involved in the growth of the hormone-responsive MCF-7 and -resistant MDA-MB-231 human breast cancer cell lines.

Original languageEnglish (US)
Pages (from-to)1371-1376
Number of pages6
JournalCancer Research
Volume49
Issue number6
StatePublished - Mar 15 1989

Fingerprint

Polyamines
Growth Hormone
Ornithine Decarboxylase
Cell Culture Techniques
Breast Neoplasms
Cell Line
Putrescine
Spermidine
Hormones
Spermine
Growth
Cell Count

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Glikman, Patricia ; Manni, Andrea ; Demers, Laurence ; Bartholomew, Mary. / Polyamine Involvement in the Growth of Hormone-responsive and -resistant Human Breast Cancer Cells in Culture. In: Cancer Research. 1989 ; Vol. 49, No. 6. pp. 1371-1376.
@article{4df5133ea696443abd73c8a63c89cfe0,
title = "Polyamine Involvement in the Growth of Hormone-responsive and -resistant Human Breast Cancer Cells in Culture",
abstract = "Recent evidence indicates that hormone-responsive but not -resistant human breast cancer cells in culture are sensitive to the antiproliferative effect of the polyamine (PA) biosynthetic inhibitor a-difluoromethylor-nithine (DFMO). The present experiments were designed to investigate the potential differential involvement of the PA pathway in the growth of these different biological subtypes of human breast cancer. Thus, we evaluated the effect of DFMO on proliferation, ornithine decarboxylase (ODC) activity, and PA levels of the hormone-dependent MCF-7 and -independent MDA-MB-231 breast cancer cell lines. When tested at comparable cell density, the two cell lines had similar levels of ODC activity and PA. Administration of DFMO (0.01, 0.1, 1, 4 mm) for 6 days caused a similar dose-dependent inhibition of proliferation (up to approximately 15{\%} of control) associated with suppression of ODC activity to undetectable levels at the highest dose. In both cell lines, putrescine and spermidine levels were maximally suppressed by doses of DFMO > 0.1 mM. Higher doses of DFMO (1 and 4 mM) also suppressed spermine levels to approximately 60{\%} of control. In detailed time-course studies, DFMO administration (0.1 mM) similarly suppressed by 80{\%} the rise in ODC observed in both cell lines following a medium change. At all time points, putrescine and spermidine levels were likewise suppressed to a similar extent. Addition of putrescine (0.1-2.5 mM) to DFMO-treated cells repleted cellular PA levels and restored growth to approximately 80{\%} of control in both cell lines. We conclude that, under these experimental conditions, PA are similarly involved in the growth of the hormone-responsive MCF-7 and -resistant MDA-MB-231 human breast cancer cell lines.",
author = "Patricia Glikman and Andrea Manni and Laurence Demers and Mary Bartholomew",
year = "1989",
month = "3",
day = "15",
language = "English (US)",
volume = "49",
pages = "1371--1376",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

Polyamine Involvement in the Growth of Hormone-responsive and -resistant Human Breast Cancer Cells in Culture. / Glikman, Patricia; Manni, Andrea; Demers, Laurence; Bartholomew, Mary.

In: Cancer Research, Vol. 49, No. 6, 15.03.1989, p. 1371-1376.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Polyamine Involvement in the Growth of Hormone-responsive and -resistant Human Breast Cancer Cells in Culture

AU - Glikman, Patricia

AU - Manni, Andrea

AU - Demers, Laurence

AU - Bartholomew, Mary

PY - 1989/3/15

Y1 - 1989/3/15

N2 - Recent evidence indicates that hormone-responsive but not -resistant human breast cancer cells in culture are sensitive to the antiproliferative effect of the polyamine (PA) biosynthetic inhibitor a-difluoromethylor-nithine (DFMO). The present experiments were designed to investigate the potential differential involvement of the PA pathway in the growth of these different biological subtypes of human breast cancer. Thus, we evaluated the effect of DFMO on proliferation, ornithine decarboxylase (ODC) activity, and PA levels of the hormone-dependent MCF-7 and -independent MDA-MB-231 breast cancer cell lines. When tested at comparable cell density, the two cell lines had similar levels of ODC activity and PA. Administration of DFMO (0.01, 0.1, 1, 4 mm) for 6 days caused a similar dose-dependent inhibition of proliferation (up to approximately 15% of control) associated with suppression of ODC activity to undetectable levels at the highest dose. In both cell lines, putrescine and spermidine levels were maximally suppressed by doses of DFMO > 0.1 mM. Higher doses of DFMO (1 and 4 mM) also suppressed spermine levels to approximately 60% of control. In detailed time-course studies, DFMO administration (0.1 mM) similarly suppressed by 80% the rise in ODC observed in both cell lines following a medium change. At all time points, putrescine and spermidine levels were likewise suppressed to a similar extent. Addition of putrescine (0.1-2.5 mM) to DFMO-treated cells repleted cellular PA levels and restored growth to approximately 80% of control in both cell lines. We conclude that, under these experimental conditions, PA are similarly involved in the growth of the hormone-responsive MCF-7 and -resistant MDA-MB-231 human breast cancer cell lines.

AB - Recent evidence indicates that hormone-responsive but not -resistant human breast cancer cells in culture are sensitive to the antiproliferative effect of the polyamine (PA) biosynthetic inhibitor a-difluoromethylor-nithine (DFMO). The present experiments were designed to investigate the potential differential involvement of the PA pathway in the growth of these different biological subtypes of human breast cancer. Thus, we evaluated the effect of DFMO on proliferation, ornithine decarboxylase (ODC) activity, and PA levels of the hormone-dependent MCF-7 and -independent MDA-MB-231 breast cancer cell lines. When tested at comparable cell density, the two cell lines had similar levels of ODC activity and PA. Administration of DFMO (0.01, 0.1, 1, 4 mm) for 6 days caused a similar dose-dependent inhibition of proliferation (up to approximately 15% of control) associated with suppression of ODC activity to undetectable levels at the highest dose. In both cell lines, putrescine and spermidine levels were maximally suppressed by doses of DFMO > 0.1 mM. Higher doses of DFMO (1 and 4 mM) also suppressed spermine levels to approximately 60% of control. In detailed time-course studies, DFMO administration (0.1 mM) similarly suppressed by 80% the rise in ODC observed in both cell lines following a medium change. At all time points, putrescine and spermidine levels were likewise suppressed to a similar extent. Addition of putrescine (0.1-2.5 mM) to DFMO-treated cells repleted cellular PA levels and restored growth to approximately 80% of control in both cell lines. We conclude that, under these experimental conditions, PA are similarly involved in the growth of the hormone-responsive MCF-7 and -resistant MDA-MB-231 human breast cancer cell lines.

UR - http://www.scopus.com/inward/record.url?scp=0024597109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024597109&partnerID=8YFLogxK

M3 - Article

C2 - 2493979

AN - SCOPUS:0024597109

VL - 49

SP - 1371

EP - 1376

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 6

ER -